Skip to main content
OpenTrials
Completed

NCT Number: NCT04180254

Evaluation and Optimization of Hearing Devices in 3-D Complex Audio Environments Study 3 (HEAR3D_CE3)

A methodical evaluation of novel sound changing principles in CE-labelled Sonova brand hearing instruments (e.g. Phonak hearing instruments) is intended to be conducted on hearing impaired participants. These sound changing principles are enabled by respective hearing instrument technologies and hearing instrument algorithms. The aim of the study is to investigate and assess strengths and weaknesses of these novel sound changing principles in terms of hearing performance to determine their application in hearing instruments (Phase of development). Both, objective laboratory measurements as well as subjective evaluations in real life environment will be carried out. This will be a controlled, single blinded and randomised active comparator clinical evaluation which will be conducted mono centric at the University Hospital of Zürich.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–85 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University Hospital Zurich

Zurich, 8091, Switzerland

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Participants fulfilling any of the following inclusion criteria are eligible for the study:

  • Adult persons (minimum age: 18 years)
  • Healthy outer ear (without previous surgical procedures, except cochlear implantation)
  • Ability to fill in a questionnaire conscientiously
  • Informed Consent as documented by signature

Normal hearing participants

  • Adult persons with audiometric normal hearing thresholds

Hearing impaired participants

  • Adult hearing impaired persons with and without (experience with) hearing aids
  • Adult hearing impaired persons with cochlear implant(s)

The presence of any one of the following exclusion criteria will lead to exclusion of the participant:

  • Contraindications to the MD in this study, e.g. known hypersensitivity or allergy to the investigational product
  • Limited mobility and not in the position to attend weekly appointments
  • Limited ability to describe listening impressions/experiences and the use of the hearing aid
  • Inability to produce a reliable hearing test result
  • Massively limited dexterity
  • Known psychological problems
  • Known central hearing disorders

Treatment and study plan

Effect of several processing on the auditory distance perception

Procedure

The focus is a comparison of hearing instrument algorithms on the auditory distance perception

Primary outcomes

  1. Success rate of the distance discrimination

    Time frame: 8 weeks

    Participants are asked whether an audio stimulus is closer or further at the end of the stimulus than at its beginning. The success rate is measured as a function of the test conditions.

Sponsors and collaborators

Lead sponsor

Sonova AG

Industry

Collaborators

  • Swiss Commission for Technology and Innovation

Registry information

Official study title

Evaluation and Optimization of Hearing Devices in 3-D Complex Audio Environments Study 3

Important dates

Study start
2019
Primary completion
2020
Study completion
2020
First posted
Nov 27, 2019
Registry last updated
Sep 2, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.